血栓弹力图-血小板映射可安全提前紧急冠状动脉旁路移植术
本研究比较了P2Y12抑制剂无反应者(TEG-PM提示ADP抑制率<50%)与未用P2Y12抑制剂的紧急住院CABG患者,发现无反应者手术等待时间更短(1.6±0.1天 vs 2.1±0.1天,P<.01),输血量无差异(1.6±0.2 vs 1.6±0.4单位,P=.91),且比STS推荐提前至少3天手术。
要点
- TEG-PM可识别P2Y12无反应者,安全缩短紧急CABG术前等待时间。
- P2Y12无反应者与未用药者输血需求无差异。
- 常规TEG-PM可降低术前住院时间及费用。
核心结论
- TEG-PM识别P2Y12无反应者后紧急CABG可安全提前,不增加输血需求。
研究设计与样本
- 回顾性队列研究,纳入2015-2019年221例TEG-PM提示ADP抑制率<50%的P2Y12无反应者,对照为232例未用P2Y12抑制剂的紧急住院CABG患者。
主要发现
- P2Y12无反应者从心脏外科会诊到CABG平均1.6±0.1天,对照组2.1±0.1天(P<.01)。
- 两组平均输血单位总数分别为1.6±0.2和1.6±0.4(P=.91)。
临床怎么用
- 对术前使用P2Y12抑制剂的紧急CABG患者,可用TEG-PM识别无反应者以安全提前手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Society of Thoracic Surgeons current (STS) guidelines recommend delaying coronary artery bypass graft surgery (CABG) for several days or performing platelet function testing in stable patients who received P2Y12 inhibitors. Our program routinely uses thromboelastography-platelet mapping (TEG-PM) to expedite CABG in P2Y12 nonresponders. We hypothesize that P2Y12 nonresponders had no difference in length of stay to surgery and blood product transfusion compared with patients undergoing urgent inpatient CABG not treated with a P2Y12 inhibitor. METHODS: A total of 221 patients from 2015 to 2019 were P2Y12 nonresponders based on TEG-PM result of less than 50% adenosine diphosphate inhibition. The control group was 232 consecutive patients who also had urgent inpatient CABG but were not treated preoperatively with a P2Y12 inhibitor. Exclusion criteria were identical between groups. RESULTS: Sixty-seven percent of inpatient CABG patients who were treated preoperatively with a P2Y12 inhibitor were nonresponders. The mean number of days from cardiac surgical consultation to CABG in the TEG-PM nonresponders group was 1.6 ± 0.1 vs 2.1 ± 0.1 in the control group (P < .01). The mean total number of blood product units transfused was 1.6 ± 0.2 in the TEG-PM nonresponders group vs 1.6 ± 0.4 in the control group (P = .91). CONCLUSIONS: Our results demonstrate a very high incidence of P2Y12 nonresponders among patients undergoing urgent CABG at our program. These patients underwent surgery at least 3 days earlier than STS recommendations and common practice with no difference in transfusion requirement. Routine use of TEG-PM to identify P2Y12 nonresponders can safely decrease preoperative hospital length of stay and associated cost and improve resource utilization and patient satisfaction.
引用
- Rogers AL, Allman RD, Fang X, et al. Thromboelastography-Platelet Mapping Allows Safe and Earlier Urgent Coronary Artery Bypass Grafting. Ann Thorac Surg. 2021. PMID: 34437860. doi:10.1016/j.athoracsur.2021.07.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。